Dashboard
Manage Tickers

STTKShattuck Labs, Inc.


$ 3.69 $ -0.18 (-4.65 %)    

Monday, 16-Sep-2024 15:53:41 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.35 $ 0.29 (0.06 %)
DIA $ 417.53 $ 2.59 (0.62 %)
SPY $ 562.91 $ 1.44 (0.26 %)
TLT $ 101.29 $ 0.67 (0.66 %)
GLD $ 238.65 $ 0.05 (0.02 %)
$ na
$ 3.87
$ 3.67 x 122
$ 3.70 x 309
$ 3.65 - $ 3.87
$ 1.33 - $ 11.76
131,875
na
181.84M
$ 0.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

shattuck-labs-stock-a-deep-dive-into-analyst-perspectives-7-ratings
Shattuck Labs Stock: A Deep Dive Into Anal...
08/27/2024 16:00:25

hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Shat...
08/27/2024 14:07:49

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $16 price t...

citigroup-maintains-buy-on-shattuck-labs-lowers-price-target-to-8
Citigroup Maintains Buy on Shattuck Labs, ...
08/15/2024 14:22:44

Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $9 to $8.

assessing-shattuck-labs-insights-from-7-financial-analysts
Assessing Shattuck Labs: Insights From 7 F...
08/02/2024 13:00:27

hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Shat...
08/02/2024 12:28:20

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $16 price t...

needham-reiterates-buy-on-shattuck-labs-maintains-8-price-target
Needham Reiterates Buy on Shattuck Labs, M...
08/02/2024 12:02:50

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $8 price target.

shattuck-labs-q2-eps-042-misses-041-estimate-sales-161m-beat-66000k-estimate
Shattuck Labs Q2 EPS $(0.42) Misses $(0.41...
08/01/2024 20:45:54

Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.4...

workday-to-rally-over-52-here-are-10-top-analyst-forecasts-for-thursday
Workday To Rally Over 52%? Here Are 10 Top...
06/20/2024 12:11:28

hc-wainwright--co-maintains-buy-on-shattuck-labs-lowers-price-target-to-16
HC Wainwright & Co. Maintains Buy on Shatt...
06/20/2024 10:22:01

HC Wainwright & Co. analyst Joseph Pantginis maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price targe...

citigroup-maintains-buy-on-shattuck-labs-lowers-price-target-to-9
Citigroup Maintains Buy on Shattuck Labs, ...
06/17/2024 14:54:24

Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $10 to...

assessing-shattuck-labs-insights-from-6-financial-analysts
Assessing Shattuck Labs: Insights From 6 F...
06/14/2024 16:00:16

needham-maintains-buy-on-shattuck-labs-lowers-price-target-to-8
Needham Maintains Buy on Shattuck Labs, Lo...
06/14/2024 15:51:22

Needham analyst Gil Blum maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $12 to $8.

shattuck-labs-discloses-updated-interim-data-from-phase-1b-dose-expansion-clinical-trial-of-sl-172154-in-combination-with-azacitidine-in-frontline-higher-risk-myelodysplastic-syndromes-and-tp53-mutant-acute-myeloid-leukemia-patients
Shattuck Labs, Discloses Updated Interim D...
06/14/2024 10:16:34

The company observed 67% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial com...

shattuck-labs-granted-orphan-drug-designation-by-fda-for-sl-172154-in-acute-myeloid-leukemia
Shattuck Labs Granted Orphan Drug Designat...
06/10/2024 11:37:04

hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Shat...
05/15/2024 15:49:50

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

shattuck-labs-to-present-additional-data-from-phase-1b-dose-expansion-trial-of-sl-172154-trial-at-eha-2024-congress-jun-14
Shattuck Labs To Present Additional Data F...
05/14/2024 20:25:48

needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target
Needham Reiterates Buy on Shattuck Labs, M...
05/14/2024 17:11:49

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target
Needham Reiterates Buy on Shattuck Labs, M...
05/03/2024 10:23:43

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Shat...
05/02/2024 17:15:17

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

shattuck-labs-cash-and-cash-equivalents-and-investments-of-1146m-for-the-quarter-ended-march-31-2024--will-be-sufficient-to-fund-its-operations-into-2026
Shattuck Labs Cash And Cash Equivalents An...
05/02/2024 12:14:41

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION